278 related articles for article (PubMed ID: 31348209)
1. Laparoscopic Hysterectomy Route, Resource Use, and Outcomes: Change After Power Morcellation Warning.
Desai VB; Wright JD; Lin H; Gross CP; Sallah YH; Schwartz PE; Xu X
Obstet Gynecol; 2019 Aug; 134(2):227-238. PubMed ID: 31348209
[TBL] [Abstract][Full Text] [Related]
2. Hospital variation in responses to safety warnings about power morcellation in hysterectomy.
Xu X; Desai VB; Wright JD; Lin H; Schwartz PE; Gross CP
Am J Obstet Gynecol; 2021 Jun; 224(6):589.e1-589.e13. PubMed ID: 33359176
[TBL] [Abstract][Full Text] [Related]
3. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
Harris JA; Swenson CW; Uppal S; Kamdar N; Mahnert N; As-Sanie S; Morgan DM
Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
[TBL] [Abstract][Full Text] [Related]
5. Hysterectomy Practice Patterns in the Postmorcellation Era.
Jorgensen EM; Modest AM; Hur HC; Hacker MR; Awtrey CS
Obstet Gynecol; 2019 Apr; 133(4):643-649. PubMed ID: 30870280
[TBL] [Abstract][Full Text] [Related]
6. Association of the U.S. Food and Drug Administration Morcellation Warning With Rates of Minimally Invasive Hysterectomy and Myomectomy.
Barron KI; Richard T; Robinson PS; Lamvu G
Obstet Gynecol; 2015 Dec; 126(6):1174-1180. PubMed ID: 26595561
[TBL] [Abstract][Full Text] [Related]
7. Complication rate of uterine morcellation in laparoscopic supracervical hysterectomy: a retrospective cohort study.
Smits RM; De Kruif JH; Van Heteren CF
Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():179-82. PubMed ID: 26943477
[TBL] [Abstract][Full Text] [Related]
8. Impact of power morcellator removal on hysterectomy practice patterns.
Wesol A; Woolley S
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():41-44. PubMed ID: 28599164
[TBL] [Abstract][Full Text] [Related]
9. Minimally Invasive Hysterectomy and Power Morcellation Trends in a West Coast Integrated Health System.
Zaritsky E; Tucker LY; Neugebauer R; Chou T; Flanagan T; Walter AJ; Raine-Bennett T
Obstet Gynecol; 2017 Jun; 129(6):996-1005. PubMed ID: 28486359
[TBL] [Abstract][Full Text] [Related]
10. Trends in Mode of Hysterectomy After the U.S. Food and Drug Administration Power Morcellation Advisory.
Ottarsdottir H; Cohen SL; Cox M; Vitonis A; Einarsson JI
Obstet Gynecol; 2017 Jun; 129(6):1014-1021. PubMed ID: 28486371
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
Meurs EAIM; Brito LG; Ajao MO; Goggins ER; Vitonis AF; Einarsson JI; Cohen SL
J Minim Invasive Gynecol; 2017; 24(5):843-849. PubMed ID: 28483536
[TBL] [Abstract][Full Text] [Related]
12. Reduced Complications Following Implementation of Laparoscopic Hysterectomy: A Danish Population-based Cohort Study of Minimally Invasive Benign Gynecologic Surgery between 2004 and 2018.
Settnes A; Topsoee MF; Moeller C; Dueholm M; Kopp TI; Norrbom C; Rasmussen SC; Froeslev PA; Joergensen A; Dreisler E; Gimbel H
J Minim Invasive Gynecol; 2020; 27(6):1344-1353.e3. PubMed ID: 31740432
[TBL] [Abstract][Full Text] [Related]
13. Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation.
Lum DA; Sokol ER; Berek JS; Schulkin J; Chen L; McElwain CA; Wright JD
J Minim Invasive Gynecol; 2016; 23(4):548-56. PubMed ID: 26827905
[TBL] [Abstract][Full Text] [Related]
14. Perioperative Outcomes of Minimally Invasive Sacrocolpopexy Based on Route of Concurrent Hysterectomy: A Secondary Analysis of the National Surgical Quality Improvement Program Database.
Cardenas-Trowers O; Stewart JR; Meriwether KV; Francis SL; Gupta A
J Minim Invasive Gynecol; 2020; 27(4):953-958. PubMed ID: 31404710
[TBL] [Abstract][Full Text] [Related]
15. Containment Bag Use Among Women Who Undergo Hysterectomy With Laparoscopic Power Morcellation.
Wright JD; Chen L; Melamed A; Clair CMS; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL; Xu X
Obstet Gynecol; 2022 Sep; 140(3):371-380. PubMed ID: 35926199
[TBL] [Abstract][Full Text] [Related]
16. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
17. Changes in Myomectomy Practice After the U.S. Food and Drug Administration Safety Communication on Power Morcellation.
Stentz NC; Cooney LG; Sammel M; Shah DK
Obstet Gynecol; 2017 Jun; 129(6):1007-1013. PubMed ID: 28486366
[TBL] [Abstract][Full Text] [Related]
18. Power morcellation for women undergoing laparoscopic supracervical hysterectomy - safety of procedure and clinical experience from 426 cases.
Rechberger T; Miotła P; Futyma K; Ziętek A; Filipczak A; Rechberger E; Szumiło J; Adamiak-Godlewska A
Ginekol Pol; 2016; 87(8):546-51. PubMed ID: 27629127
[TBL] [Abstract][Full Text] [Related]
19. Change in Surgical Practice for Women With Leiomyomas After the U.S. Food and Drug Administration Morcellator Safety Communication.
Clark NM; Schembri M; Jacoby VL
Obstet Gynecol; 2017 Nov; 130(5):1057-1063. PubMed ID: 29016511
[TBL] [Abstract][Full Text] [Related]
20. Longer Operative Time During Benign Laparoscopic and Robotic Hysterectomy Is Associated With Increased 30-Day Perioperative Complications.
Catanzarite T; Saha S; Pilecki MA; Kim JY; Milad MP
J Minim Invasive Gynecol; 2015; 22(6):1049-58. PubMed ID: 26070725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
